• Exchange: NYSE MKT LLC
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Rexahn Pharmaceuticals Inc

+ Add to Watchlist

RNN:US

0.7300 USD 0.0680 10.27%

As of 20:04:03 ET on 07/22/2014.

Snapshot for Rexahn Pharmaceuticals Inc (RNN)

Open: 0.6800 Day's Range: 0.6700 - 0.7400 Volume: 1,705,459
Previous Close: 0.6620 52wk Range: 0.3600 - 1.8500 1-Yr Rtn: +23.76%

Stock Chart for RNN

No chart data available.
  • RNN:US 0.7300
  • 1D
  • 1M
  • 1Y
0.6620
Interactive RNN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RNN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.1100
Est. EPS (USD) (12/2014) -0.1050
Est. PEG Ratio -
Market Cap (M USD) 129.94
Shares Outstanding (M) 178.00
30 Day Average Volume 1,496,229
Price/Book (mrq) 4.6000
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RNN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for RNN

Rexahn Pharmaceuticals, Inc. is a biopharmaceutical company. The Company develops signal inhibitor therapies for cancer, and treatments for central nervous system diseases.

Chang H AhnChairman/Chief Scientist/FounderPeter D SuzdakChief Executive Officer
Rakesh Soni "Rick"President/COOTae Heum JeongCFO/Secretary
More Company Profile & Key Executives for RNN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil